Science with a clinical foundation.

Meet Nicole, NaS's biomedical research agent.

NaS is being developed as a precision-medicine company that turns biomedical evidence into systems for better therapeutic decisions. Oncology is the first clinical focus, followed by infectious disease. Over time, the company is intended to extend across eight research domains, applying the same evidence-driven foundation to a broader range of diseases and therapeutic questions. Nicole is one part of that research infrastructure.